Global Oncolytic Virus Immunotherapy Market Analysis and Forecast Report 2030

$5,000$10,000

Oncolytic Virus Immunotherapy Market – By Application (Melanoma, Myeloma, Bladder Cancer, Ovarian Cancer, Prostrate Cancer, Lung Cancer, And Breast Cancer), By Product Type (HSV-Based Oncolytic Viruses, Vaccinia Virus-Based Oncolytic Viruses, Adenovirus-Based Oncolytic Viruses, Newcastle Disease Virus-Based Oncolytic Viruses, And Vesicular Stomatitis Virus-Based Oncolytic Viruses), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030

Description

Global Oncolytic Virus Immunotherapy Market Analysis and Forecast Report 2030

Market Overview
CRI has released a report titled Oncolytic Virus Immunotherapy Market – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2031. The market is anticipated to reach USD 678 million by 2030 at CAGR of 12.1% over the period from 2021 to 2030.. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market

Oncolytic Virus Immunotherapy Market Market: Key Players

Amgen, Inc.,
Genelux Corporation,
Cold Genesys, Inc.,
Lokon Pharma AB,
Takara Bio,
Viralytics Ltd.,
Shanghai Sunway Biotech,
Oncolytics Biotech, Inc.,
DNAtrix Therapeutics,
Transgene sa,
Turnstone Biologics,

Segmentation
The global Oncolytic Virus Immunotherapy Market is segmented as follows:

By Application

Melanoma
Bladder Cancer
Ovarian Cancer
Prostrate Cancer
Lung Cancer
Breast Cancer
Myeloma
By Product Type

HSV-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Adenovirus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses

Oncolytic Virus Immunotherapy Market Market Dynamics
Oncolytic Virus Immunotherapy Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Oncolytic Virus Immunotherapy Market Market growth?
Which segment accounted for the largest Oncolytic Virus Immunotherapy Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in CRI’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Related Reports: Global Multiplex Biomarker Imaging Market (2018 – 2023)

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Oncolytic Virus Immunotherapy Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Oncolytic Virus Immunotherapy Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Oncolytic Virus Immunotherapy Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Oncolytic Virus Immunotherapy Market : Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile

Amgen, Inc.,
Genelux Corporation,
Cold Genesys, Inc.,
Lokon Pharma AB,
Takara Bio,
Viralytics Ltd.,
Shanghai Sunway Biotech,
Oncolytics Biotech, Inc.,
DNAtrix Therapeutics,
Transgene sa,
Turnstone Biologics,
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Reviews

There are no reviews yet.

Be the first to review “Global Oncolytic Virus Immunotherapy Market Analysis and Forecast Report 2030”

[class^="wpforms-"]
[class^="wpforms-"]